NMRA
Price
$2.54
Change
-$0.12 (-4.51%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
424.41M
Intraday BUY SELL Signals
RCUS
Price
$20.22
Change
+$0.03 (+0.15%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.5B
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NMRA vs RCUS

Header iconNMRA vs RCUS Comparison
Open Charts NMRA vs RCUSBanner chart's image
Neumora Therapeutics
Price$2.54
Change-$0.12 (-4.51%)
Volume$16.08K
Capitalization424.41M
Arcus Biosciences
Price$20.22
Change+$0.03 (+0.15%)
Volume$14.86K
Capitalization2.5B
NMRA vs RCUS Comparison Chart in %
NMRA
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NMRA vs. RCUS commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMRA is a Hold and RCUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (NMRA: $2.54 vs. RCUS: $20.19)
Brand notoriety: NMRA and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NMRA: 55% vs. RCUS: 97%
Market capitalization -- NMRA: $424.41M vs. RCUS: $2.5B
NMRA [@Biotechnology] is valued at $424.41M. RCUS’s [@Biotechnology] market capitalization is $2.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NMRA’s FA Score shows that 1 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • NMRA’s FA Score: 1 green, 4 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, NMRA is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NMRA’s TA Score shows that 3 TA indicator(s) are bullish while RCUS’s TA Score has 3 bullish TA indicator(s).

  • NMRA’s TA Score: 3 bullish, 6 bearish.
  • RCUS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RCUS is a better buy in the short-term than NMRA.

Price Growth

NMRA (@Biotechnology) experienced а -11.19% price change this week, while RCUS (@Biotechnology) price change was -0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

RCUS is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($2.5B) has a higher market cap than NMRA($424M). RCUS YTD gains are higher at: 35.796 vs. NMRA (-76.038). NMRA has higher annual earnings (EBITDA): -264.06M vs. RCUS (-323M). RCUS has more cash in the bank: 831M vs. NMRA (218M). NMRA has less debt than RCUS: NMRA (20M) vs RCUS (111M). RCUS has higher revenues than NMRA: RCUS (240M) vs NMRA (0).
NMRARCUSNMRA / RCUS
Capitalization424M2.5B17%
EBITDA-264.06M-323M82%
Gain YTD-76.03835.796-212%
P/E RatioN/AN/A-
Revenue0240M-
Total Cash218M831M26%
Total Debt20M111M18%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NMRARCUS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 20 days ago
88%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NMRA
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAGEX18.900.04
+0.21%
Calamos Global Equity A
MVIAX19.14N/A
N/A
Praxis Value Index A
FIQCX30.51N/A
N/A
Fidelity Advisor Asset Manager 85% Z
TCPWX13.30N/A
N/A
Transamerica Capital Growth R6
UIVMX12.57N/A
N/A
MFS Intrinsic Value R1

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+0.15%
XNCR - RCUS
54%
Loosely correlated
-1.62%
IDYA - RCUS
51%
Loosely correlated
-1.72%
IMNM - RCUS
50%
Loosely correlated
-1.06%
APGE - RCUS
49%
Loosely correlated
-0.02%
RLAY - RCUS
48%
Loosely correlated
-2.30%
More